Assessing peripheral neuropathy

Thursday 18th February 2021

It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous about mentioning peripheral neuropathy, and often minimise its impact, as they are concerned that their treatment could be reduced or stopped.

GatewayC’s Managing Physical Effects course reviews the common side effects of cancer treatments and aims to help in the identification and management of some specific short- and long-term side effects, including peripheral neuropathy. This course features an interactive video consultation which demonstrates how a GP might assess the seriousness of the peripheral neuropathy of a colorectal cancer patient.

Find out more:

Follow us: LinkedIn | Twitter | Facebook

Latest from the Blog

Cancer Keys: COVID-19 and Neutropenic Sepsis

Cancer Keys: COVID-19 and Neutropenic Sepsis

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...

read more

Related Posts

Are COPD symptoms masking a lung cancer?

Are COPD symptoms masking a lung cancer?

Lung cancer is the 3rd most common cancer in the UK, yet the most common route to diagnosis is through emergency presentation. COPD and Lung Cancer Pre-existing conditions, such as Chronic Obstructive Pulmonary Disease (COPD), can increase a person’s risk of lung...

read more